AstraZeneca Asserts Seroquel Patent Against Teva

Law360, New York (June 29, 2007, 12:00 AM EDT) -- AstraZeneca Pharmaceuticals filed a lawsuit against Teva Pharmaceutical Industries Ltd. in a New Jersey court Thursday over a patent for AstraZeneca's multibillion-dollar anti-psychotic drug Seroquel.

AstraZeneca UK Limited and AstraZeneca Pharmaceuticals LP filed the lawsuit in the U.S. District Court for the District of New Jersey against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA Inc.

At issue in the suit is U.S. Patent Number 4,879,288, entitled “Novel Dibenzothiazepine Antipsychotic,” held by AstraZeneca Pharmaceuticals. The '288 patent had been slated to expire on March 20, 2007,...
To view the full article, register now.